Use of aristoloxazine c having anticancer activity
AssigneeKorea Institute of Oriental Medicine
InventorsJun LEE, Young Hye SEO, Byeong Cheol MOON, A Yeong LEE, Seung Mok RYU, Hyo Seon KIM
Life of this patent
Estimating the term…
Abstract
The present invention relates to an anticancer use of aristoloxazine C, and more specifically to a pharmaceutical composition and a health functional food composition which use aristoloxazine C represented by Chemical Formula 1 or an isomer or pharmaceutically acceptable salt thereof, a method for preventing, ameliorating or treating cancer by using same; and a method for isolating aristoloxazine C.
Claims10
1-8. (canceled)
A method for isolating aristoloxazine C represented by Chemical Formula 1 from Asarum heterotropoides roots, comprising the steps of:
- (a) extracting Asarum heterotropoides roots with an ethanol solvent to obtain an ethanol extract of the Asarum heterotropoides roots;
- (b) obtaining an ethyl acetate fraction by systematically fractionating the ethanol extract of the Asarum heterotropoides roots in the order of hexane, ethyl acetate and water;
- (c) performing flash chromatography on the ethyl acetate fraction by using a water-methanol mixture as an effluent solvent to obtain a fraction;
- and
- (d) purifying the aristoloxazine C by subjecting the fraction obtained after performing column chromatography to semi-preparative chromatography by using a water-acetonitrile mixture as an effluent solvent.
A method for preventing, ameliorating or treating cancer, comprising the step of administering aristoloxazine C represented by Chemical Formula 1, an isomer or a pharmaceutically acceptable salt thereof to a subject in need thereof:
17-20. (canceled)
Dependencies are inferred from the claim text.